Century Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: IPSC · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1850119
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
TL;DR
Century Therapeutics filed an 8-K on shareholder vote matters. Keep an eye on the outcome.
AI Summary
Century Therapeutics, Inc. filed an 8-K on June 16, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details the company's principal executive offices located at 25 North 38th Street, 11th Floor, Philadelphia, Pennsylvania, 19104, and provides a contact telephone number of (267) 817-5790.
Why It Matters
This filing indicates a formal process of shareholder voting is underway, which could impact corporate governance and future strategic decisions for Century Therapeutics.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate governance matters and does not indicate any immediate financial or operational risks.
Key Players & Entities
- Century Therapeutics, Inc. (company) — Registrant
- June 12, 2025 (date) — Earliest event reported
- June 16, 2025 (date) — Date of report
- 25 North 38th Street, 11th Floor, Philadelphia, Pennsylvania, 19104 (location) — Principal executive offices
- (267) 817-5790 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of Century Therapeutics' security holders?
The filing does not specify the exact matters submitted to a vote, only that it is a report on 'Submission of Matters to a Vote of Security Holders'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 12, 2025.
What is the official filing date of this 8-K report?
The 8-K report was filed as of June 16, 2025.
Where are Century Therapeutics' principal executive offices located?
The principal executive offices are located at 25 North 38th Street, 11th Floor, Philadelphia, Pennsylvania, 19104.
What is the telephone number for Century Therapeutics?
The registrant's telephone number, including area code, is (267) 817-5790.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Century Therapeutics, Inc. (IPSC).